文献速递糖尿病

长病程1型糖尿病冠状动脉粥样硬化与心肌功能障碍的风险与保护因素

Risk and protective factors for coronary atherosclerosis and myocardial dysfunction in individuals with long-duration type 1 diabetes.
PubMed 文献 · Diabetologia · 2025-08-20

本研究基于Joslin Medalists队列(1型糖尿病≥50年)的横断面数据,评估自报CVD(n=1038)及亚组CAC(n=142)和CMR(n=111)影像,分析炎症标志物和骨桥蛋白等循环因子与CVD的关联。结果显示仅32%有DKD但40%有CVD,CAC负荷高且有无DKD无差异;在非DKD组中HbA1c和骨桥蛋白与CVD独立相关。

要点

  • 长病程1型糖尿病无DKD者仍有高CAC负荷,CVD患病率达40%。
  • 非DKD组中HbA1c与CVD相关(OR 1.40,p<0.01),低血糖或血糖变异性无此关联。
  • 非DKD组中骨桥蛋白与CVD相关(β=0.50,p<0.01),其他炎症标志物无关联。

核心结论

  • 长病程1型糖尿病且无DKD、心血管代谢管理优良者仍存在高冠状动脉粥样硬化负荷。
  • 改善高血糖和减轻炎症(尤其骨桥蛋白)可能对长病程1型糖尿病CVD管理重要。

研究设计与样本

  • 横断面研究,评估Joslin Medalists(1型糖尿病≥50年)自报CVD(n=1038)。
  • 亚组接受冠状动脉钙化(CAC;n=142)和心脏磁共振(CMR;n=111)成像。
  • 使用多变量回归分析循环因子(炎症标志物和骨桥蛋白n=300)与CVD、CAC和CMR的关联,调整DKD及其他 cardiometabolic 和血糖风险因素。

主要发现

  • 仅32%参与者有DKD(eGFR <60 ml/min per 1.73 m2),但40%有CVD。
  • 尽管心血管代谢管理优良(平均血压132/64 mmHg;LDL和HDL胆固醇分别为2.10 mmol/l和1.69 mmol/l;HbA1c中位数54.1 mmol/mol [7.1%]),CAC负荷高(中位评分937),有无DKD无差异(1136 vs 878)。
  • 非DKD组相比DKD组,HbA1c与CVD相关(OR 1.40,p<0.01),低血糖或血糖变异性无关联。
  • 非DKD组相比DKD组,骨桥蛋白与CVD相关(β=0.50,p<0.01),其他炎症标志物无关联。

关键数值与推荐

  • DKD定义为eGFR <60 ml/min per 1.73 m2。
  • CAC中位评分937,有无DKD分别为1136和878。
  • HbA1c与CVD关联OR 1.40(p<0.01),骨桥蛋白β=0.50(p<0.01),均在非DKD组相比DKD组。

临床怎么用

  • 对长病程1型糖尿病无DKD者应警惕高冠状动脉粥样硬化负担,即使心血管代谢指标控制优良。
  • 管理上可关注改善高血糖和针对骨桥蛋白相关炎症,以降低CVD风险。

局限性

  • 横断面设计无法推断因果关系。
  • 部分分析样本量较小(CAC n=142,CMR n=111,骨桥蛋白n=300)。
  • CVD为自报结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: CVD remains a major cause of mortality in people with long-duration type 1 diabetes, even among those without diabetic kidney disease (DKD). We assessed biomarkers that may be associated with CVD risks among the Joslin 'Medalists', namely those with type 1 diabetes of ≥50 years. METHODS: In this cross-sectional study, participants were evaluated for self-reported CVD (n=1038), with subsets undergoing coronary artery calcium (CAC; n=142) and cardiac magnetic resonance (CMR; n=111) imaging. Using multivariable regression analysis, multiple circulating factors such as inflammatory biomarkers and osteopontin (n=300) were analysed for associations with CVD, CAC and CMR, adjusting for DKD and other cardiometabolic and glycaemic risk factors, including HbA1c, continuous glucose monitor (n=102) metrics and advanced glycation end-products (n=200). RESULTS: Only 32% of participants had DKD (eGFR <60 ml/min per 1.73 m2), but 40% had CVD. Despite having excellent cardiometabolic management (mean blood pressure of 132/64 mmHg; LDL and HDL-cholesterol of 2.10 mmol/l and 1.69 mmol/l, respectively, and a median HbA1c of 54.1 mmol/mol [7.1%]), participants exhibited a high CAC burden (median score 937), which did not differ between those with and without DKD (1136 vs 878, respectively). Among the glycaemic markers, HbA1c, but not hypoglycaemia or glycaemic variability, remained associated with CVD (OR 1.40, p<0.01) in the non-DKD group compared with the DKD group. Similarly, among the inflammatory markers, only osteopontin was associated with CVD (β=0.50, p<0.01) in the non-DKD group compared with the DKD group. CONCLUSIONS/INTERPRETATION: Ageing people with long-duration type 1 diabetes and without DKD, but with excellent cardiometabolic management, still possess a high burden of coronary atherosclerosis. Improving hyperglycaemia and mitigating inflammation, especially osteopontin, are potentially important for the management of CVD in long-duration type 1 diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Yu MG, Shah H, Jangolla S, et al. Risk and protective factors for coronary atherosclerosis and myocardial dysfunction in individuals with long-duration type 1 diabetes. Diabetologia. 2025. PMID: 40830274. doi:10.1007/s00125-025-06521-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。